Vigabatrin and retinal changes

Documenta Ophthalmologica

Volumn 104, Issue 2, 2002, Pages 171-180

  Jensen, Hanne ^a   Sjö, Ole ^a   Uldall, Peter ^b   Gram, Lennart ^b  

^a Center for Handicapped   (Denmark)

^b Dianalund Epilepsy Hospital   (Denmark)

Author keywords

Antiepileptic drugs; Electroretinography; ERG; Side effects; Vigabatrin; Visual field defects

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SENSITIVITY; ELECTRORETINOGRAPHY; EPILEPSY; EYE FUNDUS; FEMALE; HUMAN; MALE; NIGHT VISION; OSCILLATORY POTENTIAL; PERIMETRY; PHOTOPIC VISION; REFRACTION ERROR; RETINA DISEASE; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; ADULT; ANTICONVULSANTS; CONTROL GROUPS; ELECTRORETINOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIMETRY; RETINA; VIGABATRIN; VISUAL FIELDS;

EID: 0036214724     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014679804792     Document Type: Article

References (28)

1. Outer retinal dysfunction in patients treated with vigabatrin
2. Electrophysiologic evaluation of visual disturbances associated with vigabatrin
3. Severe persistent visual field constriction associated with vigabatrin
4. Multiple GABA plasma membrane transporters are expressed in the vertebrate retina
5. Analysis of the distribution of glycine and GABA in amacrine cells of the developing rabbit retina: A comparison with the ontogeny of a functional GABA transport system in retinal neurons
6. Symptomatic and asymptomatic visual loss in patients taking vigabatrin
7. Severe visual field constriction associated with vigabatrin
8. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures
9. Severe persistent visual field constriction associated with vigabatrin
10. Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin
11. Vigabatrin vs carbamazepin monotherapy in patients with newly diagnosed epilepsy
12. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
13. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmological findings
14. Vigabatrin-associated bilateral concentric visual field defects in four patients
15. Visual field defects associated with vigabatrin therapy
16. Asymptomatic as well as symptomatic defects with vigabatrin
17. A controlled study of vigabatrin and visual abnormalities
18. No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy
19. Visual field defects in patients taking vigabatrin
20. Visual dysfunction in patients receiving vigabatrin. Clinical and electrophysiologic findings
21. Diversity of GABA receptors in vertebrate outer retina
22. Electrophysiologic evaluation of a patient with visual field contraction associated with vigabatrin
23. Vigabatrin-associated visual field defects in children
24. Is the devil we know the lesser of two evils? Editorial
25. Reversibility of vigabatrin-induced visual-field defect
26. Severe persistent visual field constriction associated with vigabatrin
27. Visual field defects associated with vigabatrin: Observational cohort study
28. Severe persistent visual field constriction associated with vigabatrin